Journey Medical Corporation (DERM) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST
Company Participants
Jaclyn Jaffe – Senior Director of Corporate Operations
Claude Maraoui – Founder, President, CEO & Director
Joseph Benesch – CFO & Corporate Controller
Ramsey Alloush – COO, General Counsel & Company Secretary
Conference Call Participants
Brandon Folkes – H.C. Wainwright & Co, LLC, Research Division
Scott Henry – Alliance Global Partners, Research Division
Thomas Flaten – Lake Street Capital Markets, LLC, Research Division
Mayank Mamtani – B. Riley Securities, Inc., Research Division
Presentation
Operator
Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to Journey Medical’s Third Quarter 2025 Financial Results and Corporate Update Conference Call.
[Operator Instructions]
Participants of this call are advised that the audio of this call is being broadcast live over the Internet and is also being recorded for playback purposes. A webcast replay of this call will be available approximately 1 hour after the call for approximately 30 days.
I would now like to turn the call over to Ms. Jaclyn Jaffe, the company’s Senior Director of Corporate Operations. Please go ahead, Jaclyn.
Jaclyn Jaffe
Senior Director of Corporate Operations
Good afternoon, and thank you for participating in today’s conference call. Joining me from Journey Medical’s leadership team are Claude Maraoui, Co-Founder, President and Chief Executive Officer; and Joseph Benesch, Chief Financial Officer. Joining for the Q&A portion of the call will be Ramsey Alloush, Chief Operating Officer and General Counsel.
During this call, management will be making forward-looking statements, including statements that address among other things, Journey Medical’s expectations for future performance, operational results, financial condition and the receipt of regulatory approvals. Forward-looking statements involve risks and other factors that may cause actual results to differ materially from those statements. For more information about these risks, please refer to the risk factors described in Journey Medical’s most
Read the full article here
